Corina Gerontaki

Corina Gerontaki is a QC Engineer at Cellcolabs since August 2024, with prior experience as a Research Associate at Procella Therapeutics AB from June 2022 to July 2024, where expertise in molecular techniques, particularly qPCR, was developed. Corina conducted routine testing, developed new protocols, and collaborated with AstraZeneca and Contract Laboratory Organizations. Experience includes a master thesis project at Stockholm University focusing on neural development and stem cells, a Biomedical Analyst role at Legehuset Sverige involving COVID-19 sample analysis, and a bachelor's thesis at the University of Skövde exploring cancer as a metabolic disease. Academic qualifications include a Master's degree in Molecular Life Sciences from Stockholm University and a Bachelor's degree in Biomedical Sciences from the University of Skövde.